GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVOW) » Definitions » Short-Term Debt

Alvotech (Alvotech) Short-Term Debt : $37.55 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Short-Term Debt?

Alvotech's Short-Term Debt for the quarter that ended in Mar. 2024 was $37.55 Mil.

Alvotech's quarterly Short-Term Debt increased from Sep. 2023 ($13.59 Mil) to Dec. 2023 ($38.03 Mil) but then declined from Dec. 2023 ($38.03 Mil) to Mar. 2024 ($37.55 Mil).

Alvotech's annual Short-Term Debt increased from Dec. 2021 ($2.77 Mil) to Dec. 2022 ($19.92 Mil) and increased from Dec. 2022 ($19.92 Mil) to Dec. 2023 ($38.03 Mil).


Alvotech Short-Term Debt Historical Data

The historical data trend for Alvotech's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Short-Term Debt Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
- 2.50 2.77 19.92 38.03

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.05 22.46 13.59 38.03 37.55

Alvotech Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Alvotech Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Alvotech's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Alvotech (Alvotech) Business Description

Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.